News | Womens Cardiovascular Health | January 06, 2021

Long-term Outcomes After Coronary Bypass Show Worse Outcomes for Women

Better outcomes seen in multiple vs. single coronary artery bypass grafts (CABG) in men and sex appears to play a role in mortality

A coronary artery bypass graft (CABG) procedure where blockages in the coronaries are bypassed using a blood vessel harvested from elsewhere in the body and connected to the vessel past the blockage to supply blood to the heart. A new study shows better outcomes seen in multiple vs. single coronary artery bypass grafts (CABG) in men and sex appears to play a role in mortality. Getty Images

A coronary artery bypass graft (CABG) procedure where blockages in the coronaries are bypassed using a blood vessel harvested from elsewhere in the body and connected to the vessel past the blockage to supply blood to the heart. A new study shows better outcomes seen in multiple vs. single coronary artery bypass grafts (CABG) in men and sex appears to play a role in mortality. Getty Images

January 6, 2020 — A new Weill Cornell Medicine found the risk of dying seven years after coronary artery bypass graft (CABG) surgery was significantly lower in men receiving multiple bypass grafts rather than single grafts. The study also looked at CABG in women and there was no apparent difference between single or multiple vessel bypass procedures, but overall women had a higher mortality rate. The study published online Dec. 23 in the Journal of the American Medical Association (JAMA) Cardiology.[1] 

Led by WCM cardiology expert Mario F.L. Gaudino, M.D., analyzed data from more than 63,402 patients in New York’s Cardiac Surgery Reporting System and New York’s Vital Statistics file who underwent CABG between Jan. 1, 2005, to Dec. 31, 2014. The findings raises important questions about why cardiovascular outcomes differ by sex and underscores the need for prospective clinical trials in women. 

In this statewide cohort study, at 7 years’ follow-up, outcomes with multiple arterial grafting were better among low-risk, but not high-risk, patients. Mortality at 7 years was lower among men, but not women, undergoing multiple arterial grafting.

“Previous evidence for women has been unclear as women typically represent only about 20 percent of patients who undergo coronary artery bypass procedures overall and less than 15 percent of clinical trial participants,” Gaudino explained.

The study suggests that women have a worse pre-operative risk profile than men. Multiple arterial grafting is associated with better outcomes among low-risk, but not high-risk, patients, and the risk cutoffs differ between sexes. These data highlight the need for new studies on the outcome of multiple arterial grafts in women.

Results of the study show patients (48,155 men [76%]; mean [SD] age, 69.9 [10.5] years) in the study, women had worse baseline characteristics than men for most of the explored variables. Propensity matching yielded a total of 9,512 male pairs and 1,860 female pairs. 

At 7 years of follow-up, mortality was lower among men who underwent multiple arterial grafting (adjusted hazard ratio, 0.80; 95% CI, 0.73-0.87) but not women who underwent multiple arterial grafting (adjusted hazard ratio, 0.99; 95% CI, 0.84-1.15). 

When stratified by the estimated risk of death, the use of multiple arterial grafts was associated with better survival and a lower rate of a major adverse cardiac event among low-risk, but not high-risk, patients of both sexes, and the risk cutoff was different for men and women.

Find more articles and videos on women's cardiovascular health

Reference:

1. Mario Gaudino, MD, MSCE; Zaza Samadashvili, MD; Irbaz Hameed, MD; et al. Differences in Long-term Outcomes After Coronary Artery Bypass Grafting Using Single vs Multiple Arterial Grafts and the Association With Sex. JAMA Cardiol. Published online Dec. 23, 2020. doi:10.1001/jamacardio.2020.6585.

 

Related Content

Hershey's Chocolate display with samples and coco pods at the American College of Cardiology (ACC) 2012 annual meeting. The company was making the case that chocolate can be good for your heart, which is now supported by several studies. Photo by Dave Fornell

Hershey's Chocolate display with samples and coco pods at the American College of Cardiology (ACC) 2012 annual meeting. The company was making the case that chocolate can be good for your heart, which is now supported by several studies. Photo by Dave Fornell

News | Cardiovascular Clinical Studies | July 22, 2020
July 22, 2020 — Eating chocolate at least once a week is linked with a reduced risk of heart disease, according to re
The first 3-D images have been created of an RNA molecule known as "Braveheart" for its role in transforming stem cells into heart cells. Credit: Image courtesy Los Alamos National Laboratory

The first 3-D images have been created of an RNA molecule known as "Braveheart" for its role in transforming stem cells into heart cells. Credit: Image courtesy Los Alamos National Laboratory

News | Cardiovascular Clinical Studies | January 20, 2020
January 20, 2020 — Scientists at Los Alamos and international partners have created the first 3-D images of a special
Top Cardiology New in 2019 From the European Society of Cardioloigy (ESC)
News | Cardiovascular Clinical Studies | December 23, 2019
Environmental and lifestyle issues were popular this year, with pick up from both...
News | Cardiovascular Clinical Studies | November 26, 2019
November 26, 2019 — The University of Connecticut (UConn) Department of Kinesiology and Hartford Healthcare have sele
FDA Issues Final Guidance on Live Case Presentations During IDE Clinical Trials
News | Cardiovascular Clinical Studies | July 10, 2019
The U.S. Food and Drug Administration (FDA) issued the final guidance “Live Case Presentations During Investigational...
Veradigm Partners With American College of Cardiology on Next-generation Research Registries
News | Cardiovascular Clinical Studies | July 03, 2019
The American College of Cardiology (ACC) has partnered with Veradigm, an Allscripts business unit, to power the next...
New FDA Proposed Rule Alters Informed Consent for Clinical Studies
News | Cardiovascular Clinical Studies | November 19, 2018
The U.S. Food and Drug Administration (FDA) is proposing to add an exception to informed consent requirements for...
A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development. #SCAI, #SCAI2018

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development.  

Feature | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 – New clinical evidance shows common therapy options for psoriasis (PSO), a chronic inflammatory skin di
Intravenous Drug Use is Causing Rise in Heart Valve Infections, Healthcare Costs. #SCAI, #SCAI2018
News | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 — The opioid drug epidemic is impacting cardiology, with a new study finding the number of patients hosp